Non-small cell lung cancer is prevalent in over 75% of all lung
cancer incidence, with over 50% of the diagnoses coming in the advanced stage
of the disease. With over 150,000 new
cases expected to be diagnosed and over 155,000 lung cancer patients expected
to die in 2010, research into understanding and combating this deadly illness
is greatly needed. Novel approaches to
gaining understanding and advances in this arena are highly prized; one such
area deals with non-muscle myosin light chain kinase (NM-MLCK). This kinase is a very important enzyme in the
mechanism